BIOMEDICA poly

Roman name

Lactulose Poli

The composition and the form of

100 ml syrup contain lactoulozy 47,5-52,5% (66.7 g), galactose is not more than 16% lactose not more than 12%, fruktozy not more than 1% and ephylactozy no more than 8%; in vial 200 ml, in the box.

Of drugs

Reduction pH intestinal contents catalytic irritative bowel desintoksikatine. Decreases absorption of ammonia from the intestines, increasing its way out of the blood in the intestine, reduces proteoliticakimi bacteria toxic substances.

Indications

5.1 endogenous overproduction ammonia (treatment and prevention), chronic hepatic encephalopathy (prevention precoma and coma, treatment early psychological symptoms in patients with cirrhosis), the syndrome of decline bacteria flora ulcers caused by koliformnami species (salmonella, shigella) syndrome gnilostna dispepsii in infants.

Contraindications

Hypersensitivity, galactosemia.

Side-Effects

Diarrhoea (requires stopping treatment), venous ulcers, flatulence, loss of electrolytes.

Dosing and Administration

Inside, the day 1-3 st.logki-adult; 1-3 c.logki for children, 1-c.lojka grudnickam. In chronic gepatoengjefalopatia - 90-190 ml per day in 2-3 reception.

Directory → Metaboliki → Other metaboliki → BIOMEDICA poly